Latest Financial Position News

Southern Palladium reported a doubling in chromite recoveries at its Bengwenyama project, prompting a redesign of the processing plant and pushing the DFS completion to late Q4 2026 amid drilling delays and enhanced metallurgical work.

Kalgoorlie Gold Mining has confirmed gold mineralisation extending to 300 metres depth at its Pinjin Gold Project, triggering its most ambitious drilling campaign to date, including extensive RC, diamond, and aircore programs.

Rokeby Resources bolsters its portfolio with the acquisition of the high-grade Omeo Gold Project in Victoria, while unveiling promising exploration results at its Queensland assets and planning a delayed drilling campaign. The company has secured $4 million in capital commitments and announced key leadership changes.

HyTerra Ltd is progressing its flagship Nemaha hydrogen project with a key production test planned for Q2 2026, while expanding its global footprint through strategic partnerships and a $7 million capital raise.

Omega Oil and Gas has secured a commanding acreage position in Queensland’s Taroom Trough and fully funded an expanded drilling program to accelerate appraisal and early production.

Turaco Gold has lifted its Afema Project gold resources by 15% to 4.65 million ounces, driven by multiple deposit upgrades and maiden resource declarations. The Pre-Feasibility Study is on track for Q2 2026, underpinned by a strong cash position and ongoing drilling campaigns.

Mont Royal Resources is on track to release an updated Preliminary Economic Assessment for its Ashram Rare Earths project in May, with a promising geological review highlighting the BD-Zone as a key area for resource expansion. The company also secured a strategic non-binding MOU with Saguenay Port Authority and extended funding for critical infrastructure.

Syrah Resources delivered a record 24kt graphite production at Balama and secured US$72 million in equity to support medium-term ramp-up and Vidalia commercialisation, navigating a complex US trade environment.

Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.

RocketDNA Ltd delivered a break-even operating cash flow quarter with $2.47 million revenue, driven by soaring autonomous drone usage and the debut of its Skylink® operating system.

Alcidion Group delivered positive cashflow and strong new sales in Q3 FY26, with contract expansions in the UK and Australia. The company remains on track for a significant Electronic Patient Record contract signing in May.